Nascent Biotech, Inc. CEO Interviewed by The Wall Street Analyzer
February 05, 2020 10:44 ET
|
Nascent Biotech, Inc.
San Diego, CA, Feb. 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) is pleased to release a recent interview with company President | CEO Sean Carrick, on The...
Nascent Biotech Founder, Dr. Mark Glassy, Will Present at the Clinical Operation in Oncology Trials Meeting, in San Diego in February
January 30, 2020 10:00 ET
|
Nascent Biotech, Inc.
SAN DIEGO, CA , Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will be presenting on “Navigating the Unique Challenges Presented...
Nascent Biotech, Inc. Featured in New Research Update
January 15, 2020 10:04 ET
|
Nascent Biotech, Inc.
San Diego, CA, Jan. 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO), an emerging biotech company, with IND Clearance and IRB approval to begin Clinical trials...
Nascent Biotech Receives One Million Dollar Commitment From TRITON FUNDS LP
September 11, 2019 08:30 ET
|
Nascent Biotech, Inc.
SAN DIEGO, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB:NBIO), a biopharmaceutical company focusing on the development of monoclonal antibodies for the...
Nascent Biotech Has Entered into an Agreement to Perform Phase I Clinical Study for Brain Cancer
August 19, 2019 14:04 ET
|
Nascent Biotech, Inc.
Study Planned for Multiple Brain Cancer Types in Phase I Setting San Diego, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO), today announced they...
Nascent Biotech Officers Convert Liability to Stock in the Company
June 05, 2019 09:00 ET
|
Nascent Biotech, Inc.
San Diego, CA, June 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTC: NBIO) announced today that two of its Senior Officers have converted the Company’s liability to them...
Nascent Biotech Founder, Dr. Mark Glassy, Will Present at AAI Convention in San Diego
May 09, 2019 08:30 ET
|
Nascent Biotech, Inc.
SAN DIEGO, CA, May 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) founder Dr. Mark C. Glassy will present an abstract on a natural human lgG1 mAb, Pritumumab,...
Nascent Biotech Moves Corporate Offices to San Diego
April 09, 2019 12:53 ET
|
Nascent Biotech, Inc.
San Diego, CA, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTCQB: NBIO) has moved their corporate offices to San Diego, CA. Nascent CEO Sean Carrick stated,...
Nascent Biotech Receives Clearance From FDA to Begin Phase I Human Trials in Brain Cancer
December 11, 2018 08:00 ET
|
Nascent Biotech, Inc.
Vero Beach, FL, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nascent Biotech, Inc. (OTC: NBIO) received US Food and Drug Administration (FDA) Clearance to begin Phase 1 Clinical Trials...